Possible side effects include: Hypoglycemia (low blood sugar) Joint and muscle pain Headaches and nausea Injection site irritation Potential increased risk of certain cancers with prolonged high-dose use Acromegaly-like symptoms (enlarged facial features, hands, or feet) with extended high-dose usehutechlabusa.com+1catalystcliniclondon.com+1pathofpeds.com+8anabolicsza.com+8hutechlabusa.com+8catalystcliniclondon.com+9cleanfarma.ca+9pathofpeds.com+9catalystcliniclondon.com+3pathofpeds.com+3pathofpeds.com+3 Monitoring blood sugar levels and adhering to recommended dosages can mitigate some risks
However, this medication is not approved for weight loss purposes
Primary pathological features include hepatic fat accumulation, inflammation, fibrosis, and ballooning degeneration of hepatocytes
What the tentative approval confirms: The generic product meets FDA standards for safety, quality, and efficacy The application has cleared scientific and regulatory review The only remaining barrier is Novo Nordisk's residual patent protections What it does not mean: The product can be sold or prescribed today in the US Prices will drop immediately Compounded semaglutide remains a legal alternative (it does not see below) The key legal event to watch is patent litigation
While it can be effective for weight loss and blood sugar control, these benefits can sometimes come with side effects like tiredness
